Hjem
Bjørg Tilde Svanes Fevangs bilde

Bjørg Tilde Svanes Fevang

Professor
  • E-postBjorg-Tilde.Fevang@uib.no
  • Telefon+47 412 25 480
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) 2021. Periodontitis in patients with systemic lupus erythematosus: A nation-wide study of 1990 patients. Journal of Periodontology. 1-8.
  • Vis forfatter(e) 2020. Strukturert pasientforlop ved urinsyregikt. Tidsskrift for Den norske legeforening. 137-141.
  • Vis forfatter(e) 2020. Risk of cancer in 767 patients with giant cell arteritis in Western Norway: a retrospective cohort with matched controls. Journal of Rheumatology. 722-729.
  • Vis forfatter(e) 2020. Major differences in medical and surgical treatment of psoriatic arthritis and rheumatoid arthritis: a comparison of two historic cohorts. Scandinavian Journal of Rheumatology. 267-270.
  • Vis forfatter(e) 2019. Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study. Arthritis Research & Therapy. 1-10.
  • Vis forfatter(e) 2019. Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis. Scandinavian Journal of Rheumatology. 87-95.
  • Vis forfatter(e) 2019. Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: Open‐label extension of the NOR‐SWITCH trial. Journal of Internal Medicine. 653-669.
  • Vis forfatter(e) 2018. The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapy. Arthritis Research & Therapy. 11 sider.
  • Vis forfatter(e) 2018. Predictors for orthopaedic surgery in patients with rheumatoid arthritis: results from a retrospective cohort study of 1010 patients diagnosed from 1972 to 2009 and followed up until 2015. Scandinavian Journal of Rheumatology. 282-290.
  • Vis forfatter(e) 2018. Incidence and predictive factors for orthopedic surgery in patients with psoriatic arthritis. Journal of Rheumatology. 1532-1540.
  • Vis forfatter(e) 2018. Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases. International Journal of Cardiology. 1-8.
  • Vis forfatter(e) 2018. Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases. International Journal of Cardiology. 201-206.
  • Vis forfatter(e) 2017. Incidence of giant cell arteritis in Western Norway 1972-2012: A retrospective cohort study. Arthritis Research & Therapy. 1-10.
  • Vis forfatter(e) 2017. Cardiovascular disease risk profiles in inflammatory joint disease entities. Arthritis Research & Therapy. 10 sider.
  • Vis forfatter(e) 2017. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Annals of the Rheumatic Diseases. 2031-2037.
  • Vis forfatter(e) 2016. Reduction in orthopaedic surgery in patients with rheumatoid arthritis: a Norwegian register-based study. Scandinavian Journal of Rheumatology. 1-7.
  • Vis forfatter(e) 2015. Reduction in orthopaedic surgery in patients with rheumatoid arthritis: a Norwegian register-based study. Scandinavian Journal of Rheumatology.
  • Vis forfatter(e) 2015. Increased risk of revision for infection in rheumatoid arthritis patients with total hip replacements. Acta Orthopaedica. 469-476.
  • Vis forfatter(e) 2015. Improved survival for anatomic total shoulder prostheses: Results of 4,173 shoulder arthroplasties reported to the Norwegian Arthroplasty Register from 1994 through 2012. Acta Orthopaedica. 63-70.
  • Vis forfatter(e) 2014. Hip replacement surgery in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 1194-1197.
  • Vis forfatter(e) 2013. Pain and function in eight hundred and fifty nine patients comparing shoulder hemiprostheses, resurfacing prostheses, reversed total and conventional total prostheses. International Orthopaedics. 59-66.
  • Vis forfatter(e) 2012. Good function after shoulder arthroplasty 1,107 patients with 4 different diagnoses from the Norwegian Arthroplasty Register. Acta Orthopaedica. 467-473.
  • Vis forfatter(e) 2010. Risk of Revision for Infection in Primary Total Hip and Knee Arthroplasty in Patients With Rheumatoid Arthritis Compared With Osteoarthritis: A Prospective, Population-Based Study on 108,786 Hip and Knee Joint Arthroplasties From the Norwegian Arthroplasty Register. Arthritis Care and Research. 473-479.
  • Vis forfatter(e) 2010. Improved results of primary total hip replacement. Acta Orthopaedica. 649-659.
  • Vis forfatter(e) 2009. Risk factors for revision after shoulder arthroplasty. Acta Orthopaedica. 83-91.
  • Vis forfatter(e) 2009. Results after 562 total elbow replacements: A report from the Norwegian Arthroplasty Register. Journal of shoulder and elbow surgery. 449-456.
  • Vis forfatter(e) 2007. Reduction in orthopedic surgery among patients with chronic inflammatory joint disease in Norway, 1994-2004. Arthritis and Rheumatism. 529-532.
  • Vis forfatter(e) 2007. 257 ankle arthroplasties performed in Norway between 1994 and 2005. Acta Orthopaedica. 575-583.
Vitenskapelig foredrag
  • Vis forfatter(e) 2013. Using the Norwegian arthroplasty register to generate a DNA biobank.
Brev til redaktøren
  • Vis forfatter(e) 2019. Increased incidence of giant cell arteritis in urban areas? Journal of Rheumatology. 327-328.
  • Vis forfatter(e) 2018. Response to: 'Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis' by Chevreau et al. Annals of the Rheumatic Diseases.
  • Vis forfatter(e) 2014. Re: a statistical analysis of ankle prosthesis from the Norwegian Arthroplasty Register. Archives of Orthopaedic and Trauma Surgery. 17-18.
Doktorgradsavhandling
  • Vis forfatter(e) 2019. Orthopaedic surgery in patients with inflammatory rheumatic joint disease. An investigation of changes over time and with improved medical treatment .
  • Vis forfatter(e) 2018. Biomarkers in early rheumatoid arthritis. Disease activity measures, prediction of treatment response and progression of radiographic damage.
Sammendrag/abstract
  • Vis forfatter(e) 2021. POS0339 Predictors of death in patients diagnosed with giant cell arteritis in Western Norway 1972-2012. Annals of the Rheumatic Diseases. 397.2-398.
  • Vis forfatter(e) 2019. 131. Survival of patients diagnosed with GCA in western Norway 1972-2012: A case-control study. Rheumatology.
  • Vis forfatter(e) 2019. 130. Cause of death in patients diagnosed with GCA in western Norway 1972-2012: A case-control study. Rheumatology.
  • Vis forfatter(e) 2018. THU0451 Cause of death in patients diagnosed with giant cell arteritis in Western Norway 1972-2012. Annals of the Rheumatic Diseases. 437-437.
  • Vis forfatter(e) 2018. SAT0534 Annual incidence of giant cell arteritis in urban and rural areas in Western Norway 1972-2012. Annals of the Rheumatic Diseases. 1122-1122.
  • Vis forfatter(e) 2018. FRI0502 Risk of cancer in patients diagnosed with giant cell arteritis in Western Norway 1972-2012. Annals of the Rheumatic Diseases. 778-778.
  • Vis forfatter(e) 2016. Mortality and survival of patients diagnosed with GCA in Bergen (Western Norway) 1972-2012. Arthritis & Rheumatology.
  • Vis forfatter(e) 2015. Epidemiology of GCA in Bergen (Western Norway) 1972-2012. Arthritis & Rheumatology.
  • Vis forfatter(e) 2010. Norwegian Arthroplasty Register: What can it tell us about trends in disease severity in RA patients? Scandinavian Journal of Rheumatology. 16-16.
Errata
  • Vis forfatter(e) 2018. Correction to: Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study. Arthritis Research & Therapy.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) 2012. A review of national shoulder and elbow joint replacement registries. Journal of shoulder and elbow surgery. 1328-1335.

Se fullstendig oversikt over publikasjoner i CRIStin.